Nucynta ER 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FVGW9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,005
Award facts
- Contract value 100% obligated
- $2,004.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,004.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta ER 100 mg tablets (60-count). This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 11, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Nucynta ER (tapentadol extended-release), a centrally acting analgesic used for pain management, exemplifies the company's role in supporting Defense Health Agency procurement requirements through its established federal contract infrastructure.
Quick answers
Who was awarded contract SPE2DB25FVGW9?
SPE2DB25FVGW9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FVGW9 worth?
The government has obligated $2,005 on SPE2DB25FVGW9.
Is contract SPE2DB25FVGW9 an order under another contract?
Yes. SPE2DB25FVGW9 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVGW9 competed?
The extent of competition for SPE2DB25FVGW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award